SGCE missense mutations that cause myoclonus-dystonia syndrome impair ε-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA
<p>Myoclonus-dystonia syndrome (MDS) is a genetically heterogeneous disorder characterized by myoclonic jerks often seen in combination with dystonia and psychiatric co-morbidities and epilepsy. Mutations in the gene encoding ε-sarcoglycan (<em>SGCE</em>) have been found in some pa...
Autors principals: | Esapa, C, Waite, A, Locke, M, Benson, M, Kraus, M, McIlhinney, R, Sillitoe, R, Beesley, P, Blake, D |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Oxford University Press
2007
|
Matèries: |
Ítems similars
-
Advances in molecular and cell biology of dystonia: Focus on torsinA
per: Pedro Gonzalez-Alegre
Publicat: (2019-07-01) -
Gait Impairment in Myoclonus–Dystonia (DYT-SGCE)
per: Ghazal Haeri, et al.
Publicat: (2019-08-01) -
ANALYZING THE EXPRESSION OF Ε-SARCOGLYCAN (SGCE) ISOFORMS IN BRAIN
per: Ana Cazurro-Gutiérrez, et al.
Publicat: (2023-10-01) -
Myoclonus-Dystonia Syndrome and E-Sarcoglycan Deficiency
per: J Gordon Millichap
Publicat: (2002-10-01) -
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion
per: Kevin Rostasy, et al.
Publicat: (2003-02-01)